Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,562 | -6,251 | -20,132 | -16,351 | -14,997 |
| Depreciation Amortization | 6,720 | 3,331 | 9,770 | 6,462 | 3,035 |
| Income taxes - deferred | N/A | N/A | 29 | N/A | N/A |
| Accounts receivable | -3,028 | -89 | -17,159 | -14,442 | -4,355 |
| Accounts payable and accrued liabilities | 4,445 | 2,108 | -1,875 | -3,867 | -2,066 |
| Other Working Capital | 458 | 1,091 | -15,801 | -16,958 | -5,282 |
| Other Operating Activity | 1,427 | -756 | 30,907 | 27,125 | 15,460 |
| Operating Cash Flow | $460 | $-566 | $-14,261 | $-18,031 | $-8,205 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -132 | -21 | -260 | -175 | -171 |
| Purchase Sale Intangibles | N/A | N/A | -75,272 | -75,272 | -75,272 |
| Other Investing Activity | 0 | 0 | -75,272 | -75,272 | -75,272 |
| Investing Cash Flow | $-132 | $-21 | $-75,532 | $-75,447 | $-75,443 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 5,000 | 22,500 | 22,500 | 22,500 |
| Debt Repayment | -188 | -133 | -485 | -387 | -251 |
| Common Stock Issued | 77 | 37 | 2,404 | 2,404 | 2,404 |
| Common Stock Repurchased | N/A | 0 | -314 | -314 | -314 |
| Other Financing Activity | -6,237 | -1,937 | 72,394 | 72,374 | 72,784 |
| Financing Cash Flow | $-1,348 | $2,967 | $96,499 | $96,577 | $97,123 |
| Exchange Rate Effect | -209 | -124 | 80 | -87 | 28 |
| Beginning Cash Position | 12,090 | 12,090 | 5,304 | 5,304 | 5,304 |
| End Cash Position | 10,861 | 14,346 | 12,090 | 8,316 | 18,807 |
| Net Cash Flow | $-1,229 | $2,256 | $6,786 | $3,012 | $13,503 |
| Free Cash Flow | |||||
| Operating Cash Flow | 460 | -566 | -14,261 | -18,031 | -8,205 |
| Capital Expenditure | -132 | -21 | -260 | -175 | -171 |
| Free Cash Flow | 328 | -587 | -14,521 | -18,206 | -8,376 |